![]() |
市場調查報告書
商品編碼
1547364
全球 NGS 樣本製備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global NGS Sample Preparation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球NGS樣本製備市場需求預計將從2023年的15.4億美元達到2032年近62.3億美元的市場規模,2024-2032年研究期間複合年成長率為16.76%。
NGS(次世代定序)樣本製備準備用於定序的生物樣本以分析遺傳物質。這項準備工作涉及幾個關鍵步驟:從細胞中提取 DNA 或 RNA、片段化核酸以及添加用於定序的接頭。然後將製備好的樣品進行擴增以建立可定序的文庫。 NGS 樣本製備的進步簡化了工作流程、提高了效率並降低了成本,使高通量定序能夠應用於基因組學、腫瘤學、傳染病和個人化醫療。準確的樣本製備對於獲得可靠的定序資料以及深入了解遺傳變異、疾病機制和演化生物學至關重要。
下一代定序 (NGS) 技術在研究和臨床環境中的使用越來越多,這是因為它們能夠快速、經濟高效地提供全面的基因組資訊,這推動了 NGS 樣本製備市場的成長。自動化平台和最佳化方案等樣品製備技術的進步正在提高 NGS 工作流程的效率和準確性,從而推動市場需求。遺傳性疾病盛行率的上升和對個人化醫療的關注推動了對高通量和可靠的 NGS 樣本製備方法的需求。此外,增加對基因組研究的投資和擴大新興市場的定序能力也有助於市場成長。
學術機構、研究組織和生物技術公司之間的合作正在促進新型 NGS 樣品製備解決方案的創新和開發。對在臨床診斷中使用 NGS 的監管支持以及將 NGS 融入常規醫療實踐的持續趨勢進一步推動了市場擴張。 NGS 新應用(例如腫瘤學、傳染病診斷和生殖健康)的持續發展也增加了對高效能樣本製備技術的需求。然而,測序技術的高成本、對高技能人員的需求以及資料分析的複雜性可能會阻礙未來幾年的市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具還對全球 NGS 樣品製備市場的各個細分市場進行了包容性評估。 NGS 樣品製備市場產業的成長和趨勢為本研究提供了整體方法。
NGS 樣品製備市場市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 NGS 樣品製備市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 NGS 樣本製備市場的主要參與者包括 Qiagen、Thermo Fisher Scientific Inc.、Merck KGaA、F. Hoffmann-La Roche Ltd.、Agilent Technologies、Promega Corporation、Illumina Inc.、Integrated DNA Technologies Inc.、New England Biolabs ,Tecan貿易股份公司。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for NGS Sample Preparation Market is presumed to reach the market size of nearly USD 6.23 Billion by 2032 from USD 1.54 Billion in 2023 with a CAGR of 16.76% under the study period 2024-2032.
NGS (Next-Generation Sequencing) sample preparation prepares biological samples for sequencing to analyze genetic material. This preparation involves several key steps: extracting DNA or RNA from cells, fragmenting the nucleic acids, and adding adapters for sequencing. The prepared samples are then amplified to create a library that can be sequenced. Advances in NGS sample preparation have streamlined workflows, increased efficiency, and reduced costs, enabling high-throughput sequencing for applications in genomics, oncology, infectious diseases, and personalized medicine. Accurate sample preparation is crucial for obtaining reliable sequencing data and achieving insights into genetic variations, disease mechanisms, and evolutionary biology.
The growing use of next-generation sequencing (NGS) technologies in research and clinical settings is driven by their capacity to provide comprehensive genomic information quickly and cost-effectively, which is driving the growth of the NGS sample preparation market. Advancements in sample preparation techniques, such as automated platforms and optimized protocols, are improving the efficiency and accuracy of NGS workflows, thereby boosting market demand. Genetic disorders' rising prevalence and focus on personalized medicine propel the need for high-throughput and reliable NGS sample preparation methods. Additionally, increasing investments in genomic research and expanding sequencing capabilities in emerging markets contribute to market growth.
Collaborations between academic institutions, research organizations, and biotechnology companies are fostering innovation and the development of novel NGS sample preparation solutions. Regulatory support for using NGS in clinical diagnostics and the ongoing trend of integrating NGS into routine medical practice further drive market expansion. The continuous development of new applications for NGS, such as in oncology, infectious disease diagnostics, and reproductive health, is also enhancing the demand for efficient sample preparation technologies. However, the high costs of sequencing technologies, the need for highly skilled personnel, and the complexity of data analysis may hinder market growth in the next few years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of NGS Sample Preparation Market. The growth and trends of NGS Sample Preparation Market industry provide a holistic approach to this study.
This section of the NGS Sample Preparation Market market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the NGS Sample Preparation Market market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the NGS Sample Preparation Market market include Qiagen, Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Agilent Technologies, Promega Corporation, Illumina Inc., Integrated DNA Technologies Inc., New England Biolabs, Tecan Trading AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.